Johnson & Johnson at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Johnson & Johnson takes part in 2 sessions at Antibody Engineering 2026 in San Diego. Its program covers animal-based antibody discovery and testing complex biologic drugs for developability. Its research shows how a molecule's format shapes its physical behavior and how easily it can be developed into a medicine.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
Healthcare company whose Innovative Medicine segment develops antibodies, bispecifics and other medicines. | Talk Sun Dec 13 2:15pm–2:45pm Format Matters: Biophysical Characterization and Developability of Complex Biotherapeutics How a molecule's overall shape changes whether it can be made into a drug, across many measured antibody formats. Talk Tue Dec 15 8:10am–8:15am |
Instantly find 20 buyers from Johnson & Johnson
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect, The Antibody Society or Antibody Engineering & Therapeutics. Submit a correction